The Centers for Disease Control and Prevention intends to award a sole source, firm-fixed-price purchase order to Beijing Wantai Biological Pharmacy Enterprise Co., LTD for the purchase of IgG and IgM test kits for the detection of antibodies to hepatitis E. virus (HEV). These kits are required to conduct a crossover study that will compare HEV antibody test kits from different manufacturers for suitability in future studies. This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement.

This notice of intent is not a request for competitive quotations; however, all responses received within five (5) days of the issuance of this notice will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to Andrew Mansfield, Contract Specialist, at [email protected] by 1100 Eastern Time on April 21, 2020.